To determine how reducing aging‐associated chronic inflammation impacts leukemia development, aged wild‐type and IL‐37 transgenic (IL‐37tg) mice were transplanted with BCR‐ABL1+/Arf‐null B‐ALL cells (Figure S9A). This evidence concerns the gene CDKN2A and leukemia.